Strength of evidence varies strongest for FDA-approved or well-studied indications, preliminary for emerging longevity uses
Not all patients will respond to therapy, and individual results may vary
Their analysis of GLP-1 RA effectiveness by sex covered 19,906 patients in six trials
Tirzepatide, also known by its brand name Mounjaro, is a dual-acting peptide that targets two key receptors involved in appetite suppression and insulin sensitivity
Formulated for both day and night use, it helps protect your skin from environmental stressors during the day and promotes continuous regeneration and repair while you sleep
Teichman SL, Neale A, Lawrence B, Gagnon C, Castaigne JP, Frohman LA